Changes of Corneal Endothelial Cells and Central Corneal Thickness in Patients with Psoriasis

International Journal of Medical Science
© 2024 by SSRG - IJMS Journal
Volume 11 Issue 4
Year of Publication : 2024
Authors : Eman Najm Aldeen Essa, Afraa Salman, Jamal Khaddam
pdf
How to Cite?

Eman Najm Aldeen Essa, Afraa Salman, Jamal Khaddam, "Changes of Corneal Endothelial Cells and Central Corneal Thickness in Patients with Psoriasis," SSRG International Journal of Medical Science, vol. 11,  no. 4, pp. 6-14, 2024. Crossref, https://doi.org/10.14445/23939117/IJMS-V11I4P102

Abstract:

To evaluate corneal endothelial changes and central corneal thickness in patients with psoriasis.Methods: In this study, 90 eyes of 45 healthy persons and 90 eyes of 45 psoriasis patients attending the Eye ambulance and eye clinic at Tishreen University Hospital were studied between the years 2023-2024; all participants underwent a complete ophthalmological examination, including corneal endothelial cell counts Bynon contact specular microscopy(Perseus, CSO, Italy), where the average of three successive measurements of Endothelial Cell Density (ECD), hexogram (EX%), coefficient of variation (CV) and central corneal thickness was taken. The dry eye evaluation was performed with tear break-up(TBUT) and the Schirmer test. Results: The values of endothelial cell density (ECD) and hexagram (EX%) decreased statistically significantly in patients with psoriasis (p=0.002, p=0.0001, respectively). At the same time, the value of the covariance (CV) increased statistically significantly in the psoriasis group (P =0.0001). We did not find statistically significant differences in (CCT) between the two groups. We also found that the PASI score had a negative correlation with (ECD) and (EX%) and a positive correlation with (CV). The mean tear break-up(TBUT) and Schirmer test values were significantly lower in the psoriasis group than in the control group (p=0.0001). Conclusion: The eye examination is important in patients with psoriasis to evaluate the corneal endothelial changes, which have an important role in planning intraocular surgeries in patients with psoriasis.

Keywords:

Psoriasis, Central corneal thickness, Corneal endothelial cells.

References:

[1] Duygu Yalinbas Yeter et al., “Analysis of Corneal Densitometry and Endothelial Morphometry in Patients with Psoriasis,” Photodiagnosis and Photodynamic Therapy, vol. 36, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[2] Yureeda Qaziet et al., Corneal Transparency: Genesis, Maintenance and Dysfunction,” Brain Research Bulletin, vol. 81, no. 2-3, pp. 198-210, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[3] Fariba Ghalamkarpour et al., “Ocular Findings in Patients with Psoriasis: Is it Related to the Side Effects of Treatment or to Psoriasis Itself? A Case-Control Study,” Journal of Dermatological Treatment, vol. 31, no. 1, pp. 27-32, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[4] Emanuela Aragona et al., “Tear Film and Ocular Surface Assessment in Psoriasis,” British Journal of Ophthalmology, vol. 102, no. 3, pp. 302-308, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[5] Goktug Demirci et al, “Tear Osmolarity and Ocular Surface Parameters in Patients with Psoriasis,” Brazilian Ophthalmology Archives, vol. 80, no. 1, pp. 1-3, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[6] Noha A Edris et al., “Evaluation of Corneal Biomechanical Parameters in Psoriasis Patients: A Controlled Study,” Clinical Ophthalmology, vol. 14, pp. 1833-1837, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[7] Chia-Yi Lee et al., “Increased Risk of Keratopathy After Psoriasis: A Nationwide Population-Based Study,” PLOS ONE, vol. 13, no. 7, pp. 1-11, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[8] A. David Burden, and Brian Kirby, Psoriasis and Related Disorders, Inflammatory Dermatoses, Rook’s Textbook of Dermatology, 9 th Ed, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[9] Peter C.M. van de Kerkhof, and Frank O. Nestlé, “Papulosquamous and Eczematous Dermatosis: Psoriasis,” Dermatology, 2018.
[Google Scholar]
[10] Rosa Parisi et al., “National, Regional, and Worldwide Epidemiology of Psoriasis: Systematic Analysis and Modelling Study,” BMJ, pp. 1-15, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[11] Anna Campanati et al., “Psoriasis as An Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches,” Biomedicines, vol. 9, no. 11, pp. 1-20, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[12] Marek Roszkiewicz et al., “Environmental Risk Factors and Epigenetic Alternations in Psoriasis,” Annals of Agricultural and Environmental Medicine, vol. 27, no. 3, pp. 335-342, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[13] April W. Armstrong, and Charlotte Read, “Pathophysiology, Clinical Presentation, and Treatment of Psoriasis,” JAMA, vol. 323, no. 19, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[14] Klaudia Dopytalska et al., “Psoriasis in Special Localizations,” Reumatologia, vol. 56, no. 6, pp. 392-398, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[15] Grace W. Kimmel, and Mark Lebwohl, “Psoriasis: Overview and Diagnosis,” Evidence-Based Psoriasis, pp. 1-16, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[16] Tina Bhutani, Wilson Liao, and Mio Nakamura, Evidence-Based Psoriasis, Diagnosis and Treatment, Springer, pp. 1-148, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[17] Nilesh Kodali et al., “Current Management of Generalized Pustular Psoriasis,” Experimental Dermatology, vol. 32, no. 8, pp. 1204- 1218, 2023.
[CrossRef] [Google Scholar] [Publisher Link]
[18] Siew Eng Choon, Alexander A. Navarini, and Andreas Pinter, “Clinical Course and Characteristics of Generalized Pustular Psoriasis,” American Journal of Clinical Dermatology, vol. 23, pp. 21-29, 2022.
[CrossRef] [Google Scholar] [Publisher Link]
[19] Alan M. Menter et al., “Guidelines of Care for The Management of Psoriasis and Psoriatic Arthritis: Section 6. Guidelines of Care for The Treatment of Psoriasis and Psoriatic Arthritis: Case-Based Presentations and Evidence-Based Conclusions,” Journal of the American Academy of Dermatology, vol. 65, no. 1, pp. 137-174, 2011.
[CrossRef] [Google Scholar] [Publisher Link]
[20] Christopher Baker et al., “Treatment Goals for Moderate to Severe Psoriasis: An Australian Consensus,” Australasian Journal of Dermatology, vol. 54, no. 2, pp. 148-154, 2013.
[CrossRef] [Google Scholar] [Publisher Link]
[21] Hasan Khosravi et al., “Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation,” Journal of Drugs in Dermatology, vol. 16, no. 8, pp. 760-766, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[22] C. Stanley Chan et al., “Treatment of Severe Scalp Psoriasis: From the Medical Board of the National Psoriasis Foundation,” Journal of the American Academy of Dermatology, vol. 60, no. 6, pp. 962-971, 2009.
[CrossRef] [Google Scholar] [Publisher Link]
[23] Edward Hadeler et al., “Nail Psoriasis: A Review of Effective Therapies and Recommendations for Management,” Dermatology and Therapy, vol. 11, pp. 799-831, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[24] Mittanamalli S Sridhar, “Anatomy of Cornea and Ocular Surface,” Indian Journal of Ophthalmology, vol. 66, no. 2, pp. 190-194, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[25] Jack J. Kanski, and Brad Bowling, Clinical Ophthalmology: A Systematic Approach, Elsevier Health Sciences, UK, 2011.
[Publisher Link]
[26] Richard S. Snell, and Michael A. Lemp, Clinical Anatomy of the Eye, Wiley, 1998.
[Google Scholar] [Publisher Link]
[27] American Academy of Ophthalmology, Basic and Clinical Science Course, Section 08: External Disease and Cornea, 2024.
[Publisher Link]
[28] Dan Z. Reinstein et al., “Epithelial Thickness in the Normal Cornea: Three-dimensional Display with Artemis Very High-frequency Digital Ultrasound,” Journal of Refractive Surgery, vol. 24, no. 6, pp. 571-581, 2008.
[CrossRef] [Google Scholar] [Publisher Link]
[29] Anna M. Roszkowska et al., “Age-Related Modifications of the Corneal Endothelium in Adults,” International Ophthalmology, vol. 25, pp. 163-166, 2004.
[CrossRef] [Google Scholar] [Publisher Link]
[30] Jay H. Krachmer, Edward J. Holland, and Mark J. Mannis, Cornea, 2 nd Ed., Elsevier Mosby, Philadelphia, 2005.
[Google Scholar] [Publisher Link]
[31] Michael John Hogan, Jorge A. Alvarado, and Joan Esperson Weddell, Histology of the Human Eye, Saunders, USA, 1971.
[Publisher Link]
[32] Robert Lanza, Robert Langer, and Joseph P. Vacanti, Principles of Tissue Engineering, 4th Ed., Elsevier, 2013.
[Google Scholar] [Publisher Link]
[33] Nancy C. Joyce, Deshea L. Harris, and David M. Mello, “Mechanisms of Mitotic Inhibition in Corneal Endothelium: Contact Inhibition and TGF-β2,” Investigative Ophthalmology and Visual Science, vol. 43, no. 7, pp. 2152-2159, 2002.
[Google Scholar] [Publisher Link]
[34] Huan Sheng, and Mark A MCOptom Bullimore, “Factors Affecting Corneal Endothelial Morphology,” CORNEA, The Journal of Cornea and External Disease, vol. 26, no. 5, pp. 520-525, 2007.
[CrossRef] [Google Scholar] [Publisher Link]
[35] William M Bourne, Leif R. Nelson, and David O Hodge, “Central Corneal Endothelial Cell Changes Over a Ten-Year Period,” Investigative Ophthalmology and Visual Science, vol. 38, no. 3, pp. 779-782, 1997.
[Google Scholar] [Publisher Link]
[36] Nazmi Zengin et al., “Tear Film and Meibomian Gland Functions in Psoriasis,” Acta Ophthalmologica Scandinavica, vol. 74. no. 4, pp. 358-360, 1996.
[CrossRef] [Google Scholar] [Publisher Link]
[37] Josef Amann et al., “Increased Endothelial Cell Density in the Paracentral and Peripheral Regions of the Human Cornea,” American Journal of Ophthalmology, vol. 135, no. 5, pp. 584-590, 2003.
[CrossRef] [Google Scholar] [Publisher Link]
[38] Ahmad Kheirkhah et al., “Reduced Corneal Endothelial Cell Density in Patients with Dry Eye Disease,” American Journal of Ophthalmology, vol. 159, no. 6, pp. 1022-1026, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[39] Alessandro Lambiase, Marta Sacchetti, and Alessandra Mastropasqua, “Corneal Changes in Neurosurgically Induced Neurotrophic Keratitis,” JAMA Ophthalmology, vol. 131, no. 12, pp. 1547-1553, 2013.
[CrossRef] [Google Scholar] [Publisher Link]
[40] Kenji Inoue et al., “The Corneal Endothelium and Thickness in Type II Diabetes Mellitus,” Japanese Journal of Ophthalmology, vol. 46, no. 1, pp. 65-69, 2002.
[Google Scholar] [Publisher Link]
[41] Pedram Hamrah et al., “Corneal Sensation and Subbasal Nerve Alterations in Patients with Herpes Simplex Keratitis: An In Vivo Confocal Microscopy Study,” Ophthalmology, vol. 117, no. 10, pp. 1930-1936, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[42] Xiaodong Zheng et al., “In Vivo Confocal Microscopic Evidence of Keratopathy in Patients with Pseudoexfoliation Syndrome,” Investigative Ophthalmology and Visual Science, vol. 52, no. 3, pp. 1755-1761, 2011.
[CrossRef] [Google Scholar] [Publisher Link]
[43] M Gemenetzi, Y Yang, and A J Lotery, “Current Concepts on Primary Open-Angle Glaucoma Genetics: A Contribution to Disease Pathophysiology and Future Treatment,” Eye, vol. 26, pp. 355-369, 2012.
[CrossRef] [Google Scholar] [Publisher Link]
[44] Rupert R.A Bourne et al., “Effect of Cataract Surgery on The Corneal Endothelium: Modern Phacoemulsification Compared with Extracapsular Cataract Surgery,” Ophthalmology, vol. 111, no. 4, pp. 679-685, 2004.
[CrossRef] [Google Scholar] [Publisher Link]
[45] Jie Zhang, and Dipika V. Patel, “The Pathophysiology of Fuchs’ Endothelial Dystrophy-A Review of Molecular and Cellular Insights,” Experimental Eye Research, vol. 130, pp. 97-105, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[46] Yann Gavet, and Jean-Charles Pinoli, “Comparison and Supervised Learning of Segmentation Methods Dedicated to Specular Microscope Images of Corneal Endothelium,” International Journal of Biomedical Imaging, 2014.
[CrossRef] [Google Scholar] [Publisher Link]
[47] Teruo Nishida, and Shizuya Saika, Cornea and Sclera: Anatomy and Physiology, Elsevier Health Sciences, 2010.
[Google Scholar] [Publisher Link]
[48] Henry F. Edelhauser, “The Balance Between Corneal Transparency and Edema: The Proctor Lecture,” Investigative Ophthalmology and Visual Science, vol. 47, no. 5, pp. 1755-1767, 2006.
[CrossRef] [Google Scholar] [Publisher Link]
[49] Shao Yunliang et al., “Corneal Endothelial Cell Density and Morphology in Healthy Chinese Eyes,” CORNEA, The Journal of Cornea and External Disease, vol. 26, no. 2, pp. 130-132, 2007.
[CrossRef] [Google Scholar] [Publisher Link]
[50] Rahmi Duman et al., “Corneal Endothelial Cell Density in Healthy Caucasian Population,” Saudi Journal of Ophthalmology, vol. 30, no. 4, pp. 236-239, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[51] Taym Darwish, “Corneal Endothelial Cell Density and Shape in Healthy People in Syria,” Tishreen University Journal for Research and Scientific Studies, Health Sciences, vol. 40, no. 3, pp. 399-407, 2018.
[Google Scholar] [Publisher Link]
[52] “Corneal Endothelial Photography. Three-Year Revision. American Academy of Ophthalmology,” Ophthalmology, vol. 104, no. 8, pp. 1360-1365, 1997.
[Google Scholar] [Publisher Link]
[53] Marwa Mahmoud Abdellah et al., “Corneal Endothelial Cell Density and Morphology in Healthy Egyptian Eyes,” Journal of Ophthalmology, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[54] Mitra Tavakoli, Parwez Hossain, and Rayaz A Malik, “Clinical Applications of Corneal Confocal Microscopy,” Clinical Ophthalmology, vol. 2, no. 2, pp. 435-445, 2008.
[CrossRef] [Google Scholar] [Publisher Link]
[55] Bernard E McCarey, “Review of Corneal Endothelial Specular Microscopy for FDA Clinical Trials of Refractive Procedures, Surgical Devices, And New Intraocular Drugs and Solutions,” CORNEA, The Journal of Cornea and External Disease, vol. 27, no. 1, pp. 1- 16, 2008.
[CrossRef] [Google Scholar] [Publisher Link]
[56] D. M. Maurice, “Cellular Membrane Activity in The Corneal Endothelium of The Intact Eye,” Experientia, vol. 24, pp. 1094-1095, 1968.
[CrossRef] [Google Scholar] [Publisher Link]
[57] Beth Ann Benetz, and Jonathan H. Lass, “Specular Microscopy,” CORNEA, The Journal of Cornea and External Disease, vol. 37, pp. 7-8, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[58] Peter Isager et al., “Comparison of Endothelial Cell Density Estimated by Contact and Non-Contact Specular Microscopy,” Acta Ophthalmologica Scandinavica, vol. 78, no. 1, pp. 42-44, 2000.
[CrossRef] [Google Scholar] [Publisher Link]
[59] Perseus : ENDOTHELIAL MICROSCOPE, Csoitalia.
[Publisher Link]
[60] Nancy Huynh et al., “Biologic Response Modifier Therapy for Psoriatic Ocular Inflammatory Disease,” Ocular Immunology and Inflammation, vol. 16, no. 3, pp. 89-93, 2008.
[CrossRef] [Google Scholar] [Publisher Link]
[61] Ugur Celik et al., “A Comparison of Corneal Biomechanical Properties in Patients with Psoriasis and Healthy Subjects,” Eye and Contact Lens: Science and Clinical Practice, vol. 41, no. 2, pp. 127-129, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[62] Young Her, Ji Won Lim, and Sang Hak Han, “Dry Eye and Tear Film Functions in Patients with Psoriasis,” Japanese Journal of Ophthalmology, vol. 57, pp. 341-346, 2013.
[CrossRef] [Google Scholar] [Publisher Link]
[63] Surabhi Abbagani, Yogish Subraya Kamath, and Sudhir Nayak, “A Study on Ocular Morbidity Among Patients with Psoriasis Visiting a Tertiary Care Hospital in Karnataka, Southern India,” Ocular Immunology and Inflammation, vol. 27, no. 4, pp. 531-534, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[64] Salma Samir Omar, and Hany Ahmed Helaly, “Prevalence of Ocular Findings in A Sample of Egyptian Patients with Psoriasis,” Indian Journal of Dermatology, Venereology, and Leprology, vol. 84, no. 1, pp. 34-38, 2018.
[CrossRef] [Google Scholar] [Publisher Link]